Home3ZO0 • FRA
add
Acurx Pharmaceuticals Inc
Previous close
€5.09
Year range
€101.80 - €355.20
Market cap
11.11M USD
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.62M | -42.12% |
Net income | -1.58M | 43.26% |
Net profit margin | — | — |
Earnings per share | -0.31 | 90.31% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 7.56M | 103.85% |
Total assets | 7.69M | 99.32% |
Total liabilities | 2.42M | -25.35% |
Total equity | 5.27M | — |
Shares outstanding | 2.86M | — |
Price to book | 2.27 | — |
Return on assets | -58.61% | — |
Return on capital | -90.79% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -1.58M | 43.26% |
Cash from operations | -1.18M | 47.35% |
Cash from investing | — | — |
Cash from financing | 2.83M | 1,356.74% |
Net change in cash | 1.65M | 180.22% |
Free cash flow | -617.16K | 49.19% |
About
CEO
Founded
2017
Website
Employees
4
